Last reviewed · How we verify

Gymiso®

Assistance Publique Hopitaux De Marseille · Phase 3 active Small molecule

Gymiso is a mifepristone-based medication that acts as a progesterone receptor antagonist to induce medical abortion.

Gymiso is a mifepristone-based medication that acts as a progesterone receptor antagonist to induce medical abortion. Used for Medical abortion (pregnancy termination up to a specified gestational age).

At a glance

Generic nameGymiso®
SponsorAssistance Publique Hopitaux De Marseille
Drug classProgesterone receptor antagonist
TargetProgesterone receptor (PR)
ModalitySmall molecule
Therapeutic areaReproductive Health / Obstetrics
PhasePhase 3

Mechanism of action

Mifepristone competitively blocks progesterone receptors in the uterus, preventing the hormone from maintaining pregnancy. This leads to detachment of the endometrium and cessation of pregnancy support. It is typically used in combination with a prostaglandin analog (such as misoprostol) to complete the abortion process.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results